More ‘biosimilar’ medicines should be brought to market in the EU because of a regulatory policy shift on the need to carry ...

The APPA, if passed into law, puts an upper limit of 20 patents, but only of certain types of patents (see below), that can be asserted in a BPCIA litigation (the APPA does not affect ANDA litigations ...

Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to ...

Biosimilars and biobetters present a lucrative ... His responsibilities at Roche involved the design and implementation of development strategies for numerous novel chemical entities (NCE ...

Closes Transaction with T&T Power Group HOUSTON, TX / ACCESS Newswire / April 1, 2025 / Camber Energy, Inc. ("Camber" or the "Company") is pleased to announce the closing of a strategic transaction ...

Nandita Vijayasimha, Bengaluru Thursday, April 3, 2025, 08:00 Hrs [IST] ...

South Korea Prefilled Syringes Market The South Korea prefilled syringes market is expected to grow at a CAGR of 4.32% from 2024 to 2032, d ...

The global quest to prevent childhood cancer deaths has a long history. For decades, efforts have centred on driving innovation to produce more effective therapies, improve understanding in how and ...

The U.S. Food and Drug Administration (FDA) has released a series of announcements covering a wide range of initiatives and ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

Direct comparative efficacy studies are few, and also may have design issues ... Future therapies will hopefully include cheaper biosimilars, which have only been recently become available ...

Biosimilars are highly similar, affordable versions of original biologic medicines, offering access for over two decades. They represent a significant leap in medical treatment, offering therapies ...